EX1 0.57% 87.5¢ exopharm limited

Ann: December 2018 Quarterly Activities Report, page-6

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,452 Posts.
    lightbulb Created with Sketch. 314
    There is really no point asking me this question lol.  Off to work well before ASX ANNs out & home well after close of trade & busy looking after my patients all day.  I’ve really only just got the chance to post on fundamentals of EX1 ANN.

    A LT hold for me, so not bothered by the pips, or have time to look most days.  Human trials anticipated this year...if successful, this will be massive as someone posted earlier.  Surgical & diabetic wounds come to mind.
 
watchlist Created with Sketch. Add EX1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.